Here we showed that ARHGEF5 has a pivotal role in malignant progression, namely the acquisition of invasive/metastatic properties and promotion of tumor growth, particularly in colorectal cancer cells that gained mesenchymal phenotypes via EMT. Here, ARHGEF5 is linked to colorectal cancer.